Pharmaceutical company to sell Cold-Eeze lozenge brand

Pharmaceutical company to sell Cold-Eeze lozenge brand


The Pennsylvania-based maker of Cold-Eeze throat lozenges has announced that it has sold the brand to another pharmaceutical company for $50 million. Under the terms of the deal, Canonsburg-based Mylan has agreed to purchase a majority of the Doylestown-based ProPhase Labs Inc.'s assets and other rights related to the Cold-Eeze brand.



from Biotech News